NORRIS MEDICINES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Norris Medicines along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.48₹ 0.74
As on Sep 19, 2025, 4:01 PM IST
Norris Medicines Price Performance
Today's LowToday's High
₹16.17₹17.32
₹17.24
52 Weeks' Low52 Weeks' High
₹14.78₹27.74
₹17.24
Open Price
₹16.17
Prev. Close
₹16.50
Volume
500
Over the last 5 years, the share price of Norris Medicines has gained 28.09% CAGR. Over the past year, the corresponding return has been -7.06%.
Norris Medicines’s current P/E of -14.60x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Norris Medicines Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Norris Medicines | 1.59 | 4.11 | -9.26 | -9.93 | -7.06 | 10.29 | 28.09 |
| Sun Pharmaceutical Industries | 2.46 | 1.83 | 0.53 | -4.47 | -10.31 | 23.72 | 26.88 |
| Divi's Laboratories | 2.72 | 1.77 | -4.66 | 6.42 | 13.89 | 19.59 | 14.40 |
| Cipla | 0.10 | 1.71 | 6.22 | 5.14 | -3.85 | 15.04 | 15.46 |
| Torrent Pharmaceuticals | 2.14 | -0.21 | 14.98 | 14.09 | 8.71 | 35.04 | 21.92 |
| Dr. Reddy's Laboratories | 0.55 | 6.29 | -0.21 | 12.94 | 1.71 | 17.31 | 5.19 |
| Mankind Pharma | 3.11 | 6.77 | 14.52 | 23.06 | 9.42 | 23.16 | 13.31 |
| Zydus Lifesciences | -0.75 | 4.85 | 9.18 | 14.01 | -1.65 | 42.32 | 21.23 |
| Lupin | 0.75 | 4.56 | 6.49 | -0.13 | -5.17 | 47.48 | 14.61 |
| Alkem Laboratories | 2.04 | 3.13 | 16.34 | 14.54 | -9.45 | 19.64 | 14.17 |
| Aurobindo Pharma | 2.17 | 2.57 | 3.24 | -3.89 | -26.78 | 29.10 | 7.17 |
| Abbott India | -1.82 | -8.05 | -1.97 | 0.22 | 8.72 | 20.47 | 13.85 |
| Glenmark Pharmaceuticals | -2.16 | 7.13 | 27.12 | 40.23 | 26.25 | 77.84 | 34.53 |
| Laurus Labs | 4.19 | 5.51 | 44.52 | 54.04 | 98.51 | 22.52 | 26.75 |
| Biocon | 1.26 | 1.57 | 6.05 | 8.19 | 2.48 | 8.42 | -2.92 |
| Anthem Biosciences | 1.98 | 3.87 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
| GlaxoSmithKline Pharmaceuticals | -1.38 | -2.86 | -14.32 | -3.47 | 1.40 | 24.71 | 10.06 |
| Ipca Laboratories | 6.86 | 1.39 | 3.24 | 3.63 | -3.35 | 17.89 | 6.17 |
| Cohance Lifesciences | -7.40 | -1.19 | -8.09 | -21.72 | -22.85 | 25.51 | 19.13 |
| Gland Pharma | 0.04 | 3.93 | 18.34 | 27.73 | 11.67 | -3.43 | 2.12 |
Over the last one year, Norris Medicines has declined 7.06% compared to peers like Sun Pharmaceutical Industries (-10.31%), Divi's Laboratories (13.89%), Cipla (-3.85%). From a 5 year perspective, Norris Medicines has outperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Norris Medicines Financials
Norris Medicines Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 16.97 | 16.74 |
| 10 | 16.63 | 16.7 |
| 20 | 16.52 | 16.69 |
| 50 | 16.95 | 17 |
| 100 | 17.68 | 17.47 |
| 200 | 18.64 | 17.72 |
Norris Medicines Share Holding Pattern
In the latest quarter, Norris Medicines remained same as its previous close in promoter holding, while DII stake unchanged at 0.07%, FII holding unchanged at 0.00%, and public shareholding unchanged at 65.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Norris Medicines Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 06, 2025, 12:18 AM IST | Norris Medicines - Intimation Of Cutoff Date For Remote E-Voting And Closure Of Register Of Members & Share Transfer Books At |
| Sep 05, 2025, 11:33 PM IST | Norris Medicines - Letter To Shareholders, In Terms Of Regulation 36(1)(B) Of The SEBI Listing Regulations. |
| Sep 05, 2025, 11:26 PM IST | Norris Medicines - Reg. 34 (1) Annual Report. |
| Sep 05, 2025, 11:22 PM IST | Norris Medicines - Notice Of 34Th Annual General Meeting Of The Company. |
| Sep 01, 2025, 7:08 PM IST | Norris Medicines - Announcement under Regulation 30 (LODR)-Change in Management |
About Norris Medicines
Norris Medicines Ltd. is a Public Limited Listed company incorporated on 07/09/1990 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1990PLC086581 and registration number is 086581. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 5.82 Cr. and Equity Capital is Rs. 9.93 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. 801/P, GIDC Industrial Estate, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Vimal ShahManaging Director
- Mr. Praveen BafnaNon Executive Director
- Mr. A VadivelIndependent Director
FAQs on Norris Medicines Share Price
What is the share price of Norris Medicines?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Norris Medicines is ₹17.24 as on Sep 19, 2025.
What kind of stock is Norris Medicines?
The Norris Medicines is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Norris Medicines?
The market cap of Norris Medicines is ₹17.24 Cr as on Sep 19, 2025.
What are today's High and Low prices of Norris Medicines?
Today’s highest and lowest price of Norris Medicines are ₹17.32 and ₹16.17.
What are the 52 Week High and 52 Week Low of Norris Medicines?
The 52-week high/low is the highest and lowest price at which Norris Medicines stock has traded in the past 52-week or nearly a year. The 52-week high of Norris Medicines is ₹27.74 and 52-week low of Norris Medicines is ₹14.78 as on Sep 19, 2025.
How has the Norris Medicines performed historically in terms of returns?
The Norris Medicines has shown returns of 4.48% over the past day, 4.11% for the past month, -9.26% over 3 months, -7.06% over 1 year, 10.29% across 3 years, and 28.09% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Norris Medicines?
P/E ratio of and PB ratio of Norris Medicines are -14.60 and -1.17 on Sep 19, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data